Report
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
| Τίτλος: | Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002 |
|---|---|
| Συγγραφείς: | U.S. Army Medical Research and Development Command, PPD Development, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline |
| Πηγή: | A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members, Veterans, and Non-Veteran Civilians With PTSD Viele K. Allocation in platform trials to maintain comparability across time and eligibility. Stat Med. 2023 Jul 20;42(16):2811-2818. doi: 10.1002/sim.9750. Epub 2023 Apr 23. |
| Βάση Δεδομένων: | ClinicalTrials.gov |
καταχωρήστε σχόλιο πρώτοι!